Real world data on young patients with high-risk diffuse large B-cell lymphoma treated with R-CHOP or R-CHOEP - MYC, BCL2 and BCL6 as prognostic biomarkers.

by Mette Ølgod Pedersen, Anne Ortved Gang, Peter Brown, Michael Pedersen, Helle Knudsen, Signe Ledou Nielsen, Tim Poulsen, Tobias Wirenfeldt Klausen, Estrid Høgdall, Peter Nørgaard
Published 2017-01-01